Bone Biologics Corporation (BBLG) vs Jupiter Neurosciences, Inc. (JUNS)

A side-by-side comparison of Bone Biologics Corporation and Jupiter Neurosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

BBLG

Bone Biologics Corporation

$898130

$0.50HealthcareDelayed quote: Oct 6, 2026, 10:08 AM EDT

JUNS

Jupiter Neurosciences, Inc.

$1M

$2.39HealthcareDelayed quote: Oct 6, 2026, 10:07 AM EDT

Total return — BBLG vs JUNS

growth of $100 · dividends reinvested · last 2y

BBLG -93.3% (-74.1%/yr)JUNS -99.4% (-92.3%/yr)BBLG compounded faster over this window

Log scale — wide-divergence pair

BBLG JUNS

BBLG vs JUNS: by the numbers

•JUNS is the larger company ($1M vs $898130 market cap).
•Both run net losses; BBLG's is the smaller (0.00% vs -14220.12% net margin).

Metrics side by side

Valuation

Metric	BBLG	JUNS
P/S ratio	N/A	17.91
P/B ratio	0.23	N/A

Profitability

Metric	BBLG	JUNS
Gross margin	0.00%	88.34%
Operating margin	0.00%	-40873.19%
Net margin	0.00%	-14220.12%
ROE	-73.66%	N/A
ROIC	-78.01%	-709.40%

Growth (annualized)

Metric	BBLG	JUNS
Revenue CAGR (5Y)	N/A	-47.77%

Go deeper

Full BBLG analysis Full JUNS analysis Interactive comparison tool

Dig into the metrics

Bone Biologics ROE Jupiter Neurosciences ROE Bone Biologics operating margin Jupiter Neurosciences operating margin Bone Biologics revenue growth Jupiter Neurosciences revenue growth Bone Biologics free cash flow Jupiter Neurosciences free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.